Authors: Michelle Fay Cortez – April 7, 2022 Bloomberg The risk of developing serious bleeding or potentially deadly blood clots is elevated for months after experiencing even a mild Covid infection, Swedish researchers found. While the dangers of post-Covid clotting are well known, it’s less clear how long the risk lasts and what should be done to prevent […]
Authors: David Axe Published Apr. 07, 2022 4:49AM ET The first subvariant of Omicron, the latest major variant of the novel coronavirus, was bad. BA.1 drove record cases and hospitalizations in many countries starting last fall. The second subvariant, BA.2, was worse in some countries—setting new records for daily cases across China and parts of Europe. Now BA.1 and BA.2 have combined […]
Authors: Joseph Wilkinson, New York Daily NewsWed, April 6, 2022, 9:23 PM·2 min read A fourth shot of the Pfizer COVID-19 vaccine increased protection against viral infection for only four to seven weeks, according to a massive study published Tuesday. The study included 1.25 million people age 60 and over in Israel who received their […]
Change in reported COVID-19 cases per 100k people in the last two weeks March 23 to April 5, 2022 Half of the states are seeing COVID case numbers rise again while nationwide totals continue to fall. The big picture: The Omicron subvariant known as BA.2 is the dominant strain circulating around the U.S., accounting for almost […]
Authors: Petr Svab April 4, 2022 Updated: April 5, 2022 THE EPOCH TIMES U.S. counties with the highest rates of vaccination against COVID-19 are currently experiencing more cases than those with the lowest vaccination rates, according to data collected by the Centers for Disease Control and Prevention (CDC). The 500 counties where 62 to 95 percent of the population has been […]
Authors: Younes Zaid, PhD 1 , 2 and Fadila Guessous, PhD 3 , 4 Res Pract Thromb Haemost. 2022 Jan; 6(1): e12642.Published online 2022 Jan 25. doi: 10.1002/rth2.12642 PMCID: PMC8787413PMID : 35106430 Abstract Since the onset of the global pandemic of coronavirus disease 2019 (COVID‐19), there is an urgent need to understand the pathogenesis of the common inflammatory and thrombotic complications associated with this […]
Authors: Caitlin VanOverberghe SARS-CoV-2 can cause quick and significant bone loss—even when infections of the virus that causes COVID-19 appear to be mild. Researchers in the Department of Orthopaedic Surgery at Indiana University School of Medicine discovered that mouse models infected with the novel coronavirus lost approximately 25% of their bone mass within two weeks of contagion. […]
TAuthors: oral Shastri 1, Navkiran Randhawa 2, Ragia Aly 3, Masood Ghouse 3 PMID: 35210894PMCID: PMC8863340DOI: 10.2147/JBM.S350290 J Blood Med. 2022; 13: 69–74.Published online 2022 Feb 18. doi: 10.2147/JBM.S350290 Abstract As of September 2021, SARS-CoV-2 booster shots became widely available in the US to ensure continued protection against the virus. A temporal relationship has been previously reported between the first or second dose of the COVID-19 vaccine […]
Authors: Tom Tapp March 31, 2022 4:46pm Deadline Breaking News Alerts The CDC announced this week that the BA.2 Omicron variant, which is reportedly 30% more transmissible than the original BA.1 Omicron strain — has become dominant among new cases sequenced in the United States. That’s a startling rise for a variant that was less than 1% of all sequences as recently […]
Some therapies have been shown to work in clinical studies and other research Authors: Jared S. Hopkins Updated Mar. 31, 2022 3:12 pm ET Talhe Wall Street Journal The Food and Drug Administration authorized the first antiviral pills to treat Covid-19 from Pfizer Inc. and Merck & Co. and partner Ridgeback Biotherapeutics LP in December. The authorizations came after each drugmaker’s […]